May 19 AstraZeneca Plc :
* Brodalumab receives positive chmp opinion for treatment of adult patients with moderate-to-severe plaque psoriasis
* co's partner Leo Pharma has received positive opinion from CHMP of EMA recommending approval of Brodalumab Source text for Eikon: Further company coverage:
